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Complement-independent bystander injury
in AQP4-IgG seropositive neuromyelitis
optica produced by antibody-dependent
cellular cytotoxicity
Tianjiao Duan1,2, Alex J. Smith1 and Alan S. Verkman1*
Abstract
Cellular injury in AQP4-IgG seropositive neuromyelitis spectrum disorder (herein called NMO) involves AQP4-IgG
binding to astrocytes, resulting in astrocyte injury by complement-dependent cytotoxicity (CDC) and antibody-
dependent cellular cytotoxicity (ADCC) mechanisms. The rapid disease progression, severe tissue damage, and
abundant leukocyte infiltration seen in some NMO patients suggest a more direct mechanism for demyelination
and neurologic deficit than secondary injury from astrocyte loss. Here, we report evidence for an ‘ADCC bystander
mechanism’ in NMO involving injury to nearby cells by leukocytes following their activation by AQP4-bound AQP4-
IgG on astrocytes. In model cocultures containing AQP4-expressing and null CHO cells, AQP4-IgG and complement
killed bystander null cells to ~ 100 μm away from AQP4-expressing cells; AQP4-IgG and NK cells produced
bystander killing to ~ 300 μm, with perforin deposition seen on injured null cells. Bystander cytotoxicity was also
seen with neutrophil-mediated ADCC and in astrocyte-neuron cocultures. Mechanistic studies, including real-time
imaging, suggested that leukocytes activated by an AQP4-dependent ADCC mechanism injure bystander cells by
direct targeted exocytosis on neighboring cells and not by diffusion of soluble granule contents. In support of this
conclusion, ADCC bystander injury was preferentially reduced by an RGDS peptide that inhibits integrin adhesion.
Evidence for ADCC bystander injury to oligodendrocytes and neurons was also found in mice following intracerebral
injection of AQP4-IgG and NK cells, which was inhibited by RGDS peptide. These results establish a novel cellular
pathogenesis mechanism in AQP4-IgG seropositive NMO and provide evidence that inflammatory mechanisms can
cause widespread tissue damage in NMO independently of the secondary effects from astrocyte loss.
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Introduction
Neuromyelitis optica spectrum disorder (NMOSD) is an
inflammatory demyelinating disease of the central nervous
system distinct from multiple sclerosis. Most NMOSD pa-
tients are seropositive for IgG1 autoantibodies against
aquaporin-4 (AQP4) [31, 32], a plasma membrane water
channel expressed on astrocytes but not on other cell
types in the central nervous system [21, 39, 42]. An initiat-
ing event in seropositive NMOSD (herein called NMO) is
binding of anti-AQP4 autoantibodies (called AQP4-IgG)
to AQP4 on astrocytes [27], which causes direct astrocyte
injury by complement-dependent cytotoxicity (CDC) [23,
49, 54] and antibody-dependent cellular cytotoxicity
(ADCC) [10, 45, 47, 63] mechanisms. Injury to surround-
ing non-AQP4-expressing ‘bystander’ cells, such as oligo-
dendrocytes, neurons and endothelial cells, leads to
demyelination, neuron loss and consequent neurological
deficit, which can include visual and motor deficits. It has
been suggested that tissue damage in NMO is a secondary
consequence of astrocyte loss [24, 27, 41], though inflam-
matory mechanisms may directly damage surrounding tis-
sue in antibody-mediated autoimmunity [45].
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Injury to astrocytes by a CDC mechanism involves
AQP4-IgG binding to AQP4 followed by binding of
complement protein C1q and activation of the classical
complement pathway, resulting in the generation of ana-
phylatoxins and membrane attack complex (MAC) [4,
41, 52]. We recently reported a ‘complement bystander
injury’ mechanism in NMO in which bystander cells
near astrocytes, including oligodendrocytes, neurons and
perhaps other cells, are injured following complement
activation on astrocytes by local diffusion of short-lived,
activated complement components leading to MAC for-
mation on bystander cells [19, 60]. We proposed that
complement bystander injury may contribute to the
early and marked demyelination and neuronal injury
seen in human NMO and experimental animal models
of NMO.
Astrocyte injury by an ADCC mechanism in NMO in-
volves AQP4-IgG binding to astrocytes followed by bind-
ing and activation of various leukocytes, such as
granulocytes, macrophages or NK cells, via Fcγ receptors
[4, 34, 47, 68]. ADCC-mediated astrocyte injury can occur
by a variety of mechanisms, including release of toxic
granule contents such as perforin and proteases [53, 67].
Evidence for ADCC in NMO pathogenesis comes from
human pathology showing prominent leukocyte infiltra-
tion and activation [33, 37, 49], in vitro cell models [10,
63], and experimental animal models [47, 68].
Leukocyte infiltration is associated with severe, nec-
rotic NMO lesions [38]. Here, we postulated that an
analogous ‘ADCC bystander injury’ mechanism could
damage non-AQP4-expressing cells near astrocytes fol-
lowing Fcγ receptor-mediated leukocyte activation. We
report evidence, using coculture systems and mice, that
activation of NK cells or neutrophils by AQP4-IgG-
coated AQP4 expressing cells can lead to acute lysis of
non-AQP4 expressing neighboring cells, supporting
ADCC bystander injury as a mechanism of tissue dam-
age in NMO.
Materials and methods
Materials
Purified human monoclonal recombinant AQP4-IgG
(rAb-53) [10, 16] was provided by Dr. Jeffrey Bennett
(University of Colorado, Aurora, CO). Sera from con-
firmed seropositive NMO patients was provided by the
Circles Bloodbank of the Guthy-Jackson Charitable
Foundation. Human complement was purchased from
Innovative Research (Novi, MI) and human (control)
IgG from Thermo Fisher Scientific (Rockford, IL).
Sprague-Dawley rats were purchased from Charles River
Laboratories (Wilmington, MA) and bred at UCSF. All
animal procedures were approved by the University of
California, San Francisco Animal Care and Use Commit-
tee (IACUC).
Cell culture
Chinese hamster ovary (CHO) cells stably expressing hu-
man AQP4-M23 (named CHO-AQP4 cells), as de-
scribed [16, 44], were cultured at 37 °C in 5% CO2 95%
air in F-12 Ham’s Nutrient Mixture medium supple-
mented with 10% fetal bovine serum, 200 μg/ml genet-
icin, 100 U/ml penicillin and 100 μg/ml streptomycin.
Non-transfected CHO-K1 cells without AQP4 (called
CHO-null cells) were cultured in the same medium but
without geneticin. Human natural killer cells (NK cells)
transfected to express the high-affinity 176 V variant of
the Fcγ receptor IIIA [66] were obtained from Fox Chase
Cancer Center (Philadelphia, PA). NK cells were cul-
tured in suspension in α-MEM (Sigma-Aldrich, St.
Louis, MO) containing 0.1 mM 2-mercaptoethanol, 2
mM L-glutamine, 0.2 mM myoinositol, 10% FBS, 10%
horse serum, 2.5 μM folic acid, 5 ml non-essential amino
acids, 1 mM Na pyruvate, 1% penicillin/streptomycin,
and 100 IU/ml of human recombinant interleukin-2
(GenScript, Piscataway, NJ). Primary astrocyte-neuron
cocultures were generated from brains of embryonic day
18 Sprague-Dawley rats (neurons) or cerebral cortex of
neonatal rats (astrocytes) as described [19].
Neutrophils were isolated from human peripheral
blood by a modified Ficoll-Hypaque method [20, 40]
using density gradient centrifugation and a commercial
separation medium (Lympholyte-poly, CL5071, Cedar-
lane Labs, Burlington, NC) containing sodium metrizo-
ate and dextran 500. After separation, red cell lysis
buffer was added to the neutrophil layer to lyse residual
red cells. The isolated neutrophils were resuspended in
HBSS/HSA solution (2% HSA) at specified concentra-
tion and used within 2 h. Neutrophil purity was 97.0% as
judged by immunofluorescence using neutrophil-specific
CD66b antibody (1:200, 555723, BD Pharmingen, San
Jose, CA).
Complement-dependent cytotoxicity
CHO-AQP4 and CHO-null cells were cultured individu-
ally or at specified cell number ratios (from 1:5 to 1:50)
on coverslips in 24-well plates, and grown for 18-24 h
until confluent. For assay of CDC, CHO cells were incu-
bated for 2 h at 37 °C with 5% human complement and
10 μg/ml AQP4-IgG (or control human IgG) in Hank’s
balanced salt solution (HBSS, pH 7.2; Invitrogen, Cama-
rillo, CA).
Antibody-dependent cellular cytotoxicity
For assay of ADCC, CHO-AQP4 and CHO-null cell co-
cultures were generated as for CDC experiments. Pri-
mary neurons were grown on coverslips in 12-well
plates and astrocytes were added to neurons at a 1:20 ra-
tio before experiments. NK-92 cells overexpressing
CD16 were used as the effector cells. Cells were pre-
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incubated with 5 μg/ml AQP4-IgG (or control IgG) for
30 min at 37 °C. In some experiments, cells preincubated
with a 1:100 dilution of serum of an AQP4-IgG seroposi-
tive NMO patient. NK cells or neutrophils were then
added to the AQP4-IgG-coated CHO cells at an effector:
target cell ratio of 5:1, and incubated for an additional 1
h at 37 °C. Following treatments, cells were washed ex-
tensively with Hank’s Balanced Salt Solution (HBSS) to
remove the remaining effector cells. In some studies, NK
cells were pretreated with an inhibitor of the perforin
cytotoxic pathway, concanamycin A (CMA, 10 nM,
C9705, Sigma-Aldrich) [66] for 2 h prior to AQP4-IgG
addition. In some studies, a neutralizing anti-perforin
antibody (δG9, 10 μg/ml, BD Pharmingen, San Jose, CA)
was added together with NK cells onto the CHO cells.
In some studies, the RGD-containing peptide RGDS (or
control peptide RGES) (200 μM, Sigma-Aldrich) [28]
was pre-incubated with CHO cell cocultures for 1 h
prior to AQP4-IgG addition.
Immunofluorescence
In some experiments, a fixable red-fluorescent dead-cell
stain (L23102, amine-reactive dye, Invitrogen, Eugene, OR)
at 1:1000 dilution was added 30min prior to cell fixation.
Cells were then rinsed in PBS and fixed with 4% parafor-
maldehyde (PFA) for 15min. After fixation, cells were
blocked for 1 h with 1% BSA and 0.1% Triton-X100 in PBS,
and incubated with primary antibodies. Brains were cut as
7-μm-thick frozen sections, and blocked in the same buffer
before immunostaining. Cultures and brain sections were
incubated at 4 °C overnight with antibodies against AQP4
(sc-20812, 1:200, Santa Cruz Biotechnology, Dallas, TX),
AQP4 (sc-9888, 1:200, Santa Cruz Biotechnology, Dallas,
TX), C1q (ab71940, 1:50, abcam, Cambridge, MA), C5b-9
(ab55811, 1:200, abcam, Cambridge, MA), GFAP (AB5541,
1:1000; Millipore, Burlington, MA), MAP2 (PA5–17646, 1:
100, Thermo Fisher Scientific, Rockford, IL), perforin (δG9,
556434, 1:100, BD Pharmingen, San Jose, CA), NeuN
(ABN78, 1:200, Millipore, Burlington, MA), Olig2 (sc-
48817, 1:100, Santa Cruz Biotechnology, Dallas, TX) or
GFP (MA1–952, 1:20, Thermo Fisher Scientific, Rockford,
IL) followed by 1 h incubation with appropriate species-
specific Alexa Fluor-conjugated secondary antibody (5 μg/
ml each, Invitrogen, Camarillo, CA). Sections and cover-
slips were mounted with ProLong Gold antifade reagent
(P36931, Thermo Fisher Scientific, Rockford, IL), and im-
munofluorescence was visualized on a Nikon confocal
microscope using a 20x/0.5N.A., 60x/1.25N.A., or 100x/
1.4N.A. oil objective lens.
Real-time imaging
For live-cell real-time imaging, CHO-AQP4 / CHO-null
cell cocultures were imaged using a 20x, 0.45 NA object-
ive lens on a Nikon Eclipse Ti microscope equipped with
an environmental chamber at 37 °C and 5% CO2. CHO-
AQP4 cells were loaded with the CellTracker™ Green
CMFDA (C2925, 5 μM in HBSS) for 30 min at 37 °C, cell
tracker was removed and cells were replated with un-
labeled CHO-null cells overnight before experiments.
Control experiments verified that 100% of CHO-AQP4
cells retained the CellTracker label overnight. Cells were
then pre-incubated with 5 μg/ml AQP4-IgG for 30 min,
which was then washed away prior to imaging. For im-
aging, cells were then incubated in HBSS containing eth-
idium homodimer-1 (1 μM, Invitrogen, Eugene, OR).
Transmitted light (phase-contrast), green and red fluor-
escence images were obtained sequentially every 2 min
for a 30 min baseline period and then for 1.5 h following
addition of NK cells.
Mouse studies
AQP4 knockout (AQP4−/−) mice used in this study have
been described and extensively characterized [35]. Ex-
periments were done on weight-matched wild type and
AQP4−/− mice on a CD1 genetic background, generally
of age 16–18 weeks. Mice were anesthetized with keta-
mine (100 mg/kg) and xylazine (10 mg/kg) and mounted
on a stereotaxic frame. A midline scalp incision was
made and a burr hole of diameter 1 mm was drilled in
the skull 0.5 mm anterior and 2mm lateral to the
bregma. A glass pipette with a 40-μm-diameter tip was
inserted 3 mm deep to infuse 4 μg AQP4-IgG (or control
IgG) together with 104 GFP labeled NK-cells and 3 μM
dead cell dye ethidium homodimer (EH-1) at ~ 1 μl/min
for a total volume of 3 μl. In some experiments, AQP4-
IgG and NK cells were injected together with RGDS
peptide or RGES peptide (1 mM, 2 μl). After 90 min,
mice were anesthetized and perfused through the left
cardiac ventricle with 100 ml PBS and then 100 ml of 4%
PFA in PBS. Brain were post-fixed overnight in 4% PFA
and cryoprotected in 20% sucrose for cutting 7-μm-thick
sections on a cryostat.
Image analysis
To quantify the fraction of dead cells surrounding AQP4
expressing cells, low magnification (5x) images were
used. ImageJ software was used to draw concentric cir-
cles of 100 μm, 200 μm and 300 μm radius around single,
isolated AQP4-expressing cells. Dead and total cells
within each circle were counted from the red fluores-
cence and transmitted light images, respectively.
Statistics
Data are presented as mean ± S.E.M. Statistical ana-
lysis and graphing were performed with GraphPad
Prism 6 software. Statistical comparisons were made
using the two-way ANOVA for comparisons within a
group data set.
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Results
Complement bystander cytotoxicity in CHO cell
cocultures
A CHO cell coculture system was established to study by-
stander cytotoxicity mechanisms. CHO cells were chosen
for initial model studies because of their rapid growth on
uncoated plastic or glass, strong plasma membrane AQP4
expression following transfection, and ability to generate
cultures with well-isolated AQP4-expressing cells sur-
rounded by bystander cells. Figure 1a shows AQP4 im-
munofluorescence, with DAPI counterstain, of cocultures
containing AQP4-expressing CHO cells (CHO-AQP4)
and non-transfected CHO cells (CHO-null) at different
cell number ratios. At lower ratios, the CHO-AQP4 cells
were generally well-separated and surrounded by CHO-
null cells. Occasionally, two adjacent CHO-AQP4 cells
were seen as a consequence of cell division that occurred
between the time of plating and experiment.
A CHO-AQP4 to CHO-null cell ratio of 1:50 was used
to study complement bystander cytotoxicity, which was
done initially as a reference to compare with ADCC by-
stander experiments. To study complement bystander
cytotoxicity, cocultures were incubated with AQP4-IgG
and human complement (HC) for 2 h with a fixable dead
cell dye added at 1.5 h (Fig. 1b, top). Figure 1b (bottom,
left panel) shows several red-stained dead CHO-null
cells surrounding a dead CHO-AQP4 cell. Dead cells
were not seen with control (non-NMO) IgG in place of
AQP4-IgG, with AQP4-IgG but without HC, and in
CHO-null cells exposed to AQP4-IgG and HC (Figs. 1b,
3 right panels). Figure 1c summarizes the analysis of im-
ages from 3 cocultures in which the fraction of dead
CHO-null cells was determined at different distances
from dead CHO-AQP4 cells. Essentially all dead by-
stander CHO-null cells were seen within 100 μm of dead
CHO-AQP4 cells. Time-lapse imaging shows both
CHO-AQP4 cells (labeled with green cell tracker) and
nearby CHO-null cells were injured, with EH-1 uptake
following AQP4-IgG and human complement addition
(see Additional file 1: Video S1).
Figure 1d shows immunofluorescence of C1q, an early
complement protein that binds to the Fc portion of
AQP4-IgG and activates the classical complement path-
way, and C5b-9, the terminal membrane attack complex
(MAC) that causes cytotoxicity. When cells were ex-
posed to AQP4-IgG and human complement, C1q im-
munofluorescence was seen only on AQP4-expressing
CHO cells and not on CHO-null cells (as stained with
DAPI), whereas C5b-9 immunofluorescence was seen on
both CHO-AQP4 cells and nearby CHO-null cells.
These results, utilizing a simple model system, support
our prior data on complement bystander cytotoxicity ob-
tained in astrocyte-oligodendrocyte and astrocyte-
neuron cocultures [19, 60].
ADCC bystander killing in CHO cell cocultures
The CHO cell coculture model was then used to test
whether AQP4-IgG with NK cells could produce ADCC
bystander killing in the absence of complement. For
these experiments, cocultures were initially coated with
AQP4-IgG by incubation and washing (Fig. 2a), which
minimized non-specific solution-phase activation of NK
cells by unbound IgG. Figure 2b shows examples of ap-
parent ADCC bystander killing in which red-stained,
dead CHO-null cells were seen preferentially near dead
CHO-AQP4 cells. Analysis of experiments done in 5 co-
cultures showed that killing of bystander CHO-null cells
occurred largely with 100 μm of CHO-AQP4 cells, with
some dead cells seen at greater distances up to 300 μm
(Fig. 2c). Time course studies showed that ADCC by-
stander killing was observed at 60 min, with little cell
killing at 15 min and killing largely restricted to CHO-
AQP4 cells at 30 min (Fig. 2d). Few dead CHO cells
were seen in control studies done in the cocultures when
control (non-AQP4) IgG was used in place of AQP4-IgG
or when NK cells were not included, or in pure CHO-
null cultures exposed to AQP4-IgG and NK cells (Fig.
2e). Bystander injury to CHO-null cells nearby CHO-
AQP4 cells was also seen using serum from two sero-
positive NMO patients instead of the recombinant
AQP4-IgG antibody (Fig. 2f ).
Studies were done to investigate potential mechanisms
of ADCC bystander killing by AQP4-IgG and NK cells.
In CHO cell cocultures exposed to AQP4-IgG and NK
cells, perforin immunostaining was seen on both AQP4-
positive CHO cells and AQP4-negative CHO-null by-
stander cells (Fig. 3a), suggesting the involvement of
perforin release in bystander cell killing. Time-lapse
imaging was done to visualize the events during ADCC
bystander killing. For these studies AQP4-expressing
CHO cells were pre-labeled with cell tracker green fluor-
escent marker (with CHO-null cells not labeled) in order
to identify them during real-time imaging. Ethidium ho-
modimer was included, which is rapidly taken up and
becomes fluorescent in injured cells. Figure 3b shows
images from a time-lapse video (see Additional file 2:
Video S2). At 30 min NK cell activation was seen on a
green CHO-AQP4 cell, which became stained red at
120 min. An activated NK cell was seen at 40 min to
move to nearby bystander cells, which became stained
red at 90 min. Examination of > 20 bystander killing
events in multiple time-lapse images revealed that in all
cases bystander killing involved physical contact between
activated NK cells and bystander cells.
ADCC bystander killing in in vitro models of NMO
To investigate whether ADCC bystander killing, as dem-
onstrated in the AQP4-IgG-exposed CHO coculture /
NK cell model system, can occur in cell types that are
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Fig. 1 Complement bystander cytotoxicity in cocultures containing AQP4-expressing and null CHO cells. a AQP4 immunofluorescence (green)
with DAPI counterstain (blue) in cocultures of CHO-AQP4 and CHO-null cells plated at different cell ratios. b Complement-dependent cytotoxicity.
Cocultures at 1:50 cell ratio was incubated with 10 μg/ml AQP4-IgG (or control IgG) and 5% human complement (HC), with fixable red-
fluorescent dead cell marker (left). AQP4 immunofluorescence (green) with dead cell stain (red) for cells incubated with AQP4-IgG and HC, with
controls including cells incubated with control IgG and HC, with AQP4-IgG alone, and pure CHO-null cells incubated with AQP4-IgG and HC
(right). c Fraction of red-stained dead CHO-null cells as a function of distance from dead CHO-AQP4 cells (mean ± S.E.M., 3 slides with > 50 dead
cells analyzed, ** P<0.01 comparing AQP4-IgG + HC vs. control IgG + HC or AQP4-IgG or pure CHO-null cells by two-way ANOVA). d C1q (top)
and C5b-9 (bottom) immunofluorescence (red) in cocultures incubated as in (b), costained with AQP4 (green) and DAPI (blue). White filled arrows
indicate C5b-9 or C1q on CHO-AQP4 cells, white open arrows show C5b-9 on CHO-null cells
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Fig. 2 (See legend on next page.)
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relevant to NMO neuropathology, experiments were
done in primary astrocyte-neuron cocultures in which
AQP4 is expressed on astrocytes but not on neurons
[19, 42]. Cells were exposed to AQP4-IgG and NK cells
for 2 h. Figure 4a shows dead, red-stained MAP2-
positive neurons nearby dead GFAP-positive astrocytes.
Minimal killing was found in cocultures incubated with
control IgG and NK cells or AQP4-IgG without NK
cells. Figure 4b summarizes the fraction of dead neurons
at different distances from the center of dead astrocytes,
showing preferential killing of neurons within 300 μm of
dead astrocytes. Perforin deposition was seen on both
astrocytes and nearby neurons (Fig. 4c).
ADCC bystander killing studies were also done in the
CHO cell coculture system, but using neutrophils in-
stead of NK cells. Freshly isolated human neutrophils
were incubated with CHO cell cocultures for 1 h follow-
ing AQP4-IgG exposure. Figure 4d (left panel) shows by-
stander killing of CHO-null cells (as stained with DAPI)
nearby dead CHO-AQP4 cells (AQP4 stained), with the
inset confirming CD66b-positive neutrophil identity. Fig-
ure 4d (three center panels) shows that exposure of
CHO cell cocultures to neutrophils and AQP4-IgG pro-
duces bystander killing by an ADCC mechanism, with
killing not seen with neutrophils alone or in pure CHO-
null cell cultures. Figure 4d (right panel) summarizes the
fraction of dead CHO-null cells at different distances
from the center of dead AQP4-expressing CHO cells,
showing preferential killing of CHO-null cells within
100 μm of dead CHO-AQP4 cells.
ADCC bystander killing in a mouse model of NMO
We previously reported an ADCC model of NMO in
mice in which intracerebral administration of AQP4-IgG
and NK cells produced astrocytopathy and inflammation
[45, 47]. Because endogenous complement activity in
mouse is low [11, 46], ADCC studies in mice are not
confounded by complement activation. To investigate
whether ADCC bystander killing occurs in mouse brain
in vivo, AQP4-IgG and a small number of GFP-labeled
NK cells were injected into mouse brain together with
dead cell dye ethidium homodimer-1 (EH-1) (Fig. 5a).
Brains were fixed in situ and frozen sections were exam-
ined by confocal microscopy at high magnification to re-
solve astrocytes, NK cells and dead cells using GFAP to
identify astrocytes and a GFP antibody to identify NK
cells. Figure 5b shows many dead cells (EH-1 positive)
near the needle tract in wild type mice receiving AQP4-
IgG and GFP-NK cells. Few or no dead cells were seen
with injection of control IgG and NK cells, with AQP4-
IgG alone, or when AQP4-IgG and NK cells were
injected into AQP4−/− mice.
At high magnification, red-stained dead cells were
seen, which included GFAP immunostained astrocytes
(white) in contact with GFP immunostained GFP-NK
cells (green), as well as some nearby dead cells that were
not stained with GFAP antibody and hence not astro-
cytes (Figs. 5c, 2 right panels). Cell death was not seen
in AQP4+/+ mice receiving control IgG and NK cells or
AQP4−/− mice receiving AQP4-IgG and NK cells (Fig.
5c, two right panels). Figure 5d summarizes the fraction
of dead astrocytes associated with 0, 1 and 2 or more
dead nearby (within 100 μm) bystander cells, showing
dead bystander cells associated with more than half of
the dead astrocytes. To identify dead bystander cells,
NeuN was used as a neuron marker and Olig2 as oligo-
dendrocyte marker, with AQP4 as the astrocyte marker.
Figure 5e (left) shows bystander cell killing using AQP4
as the astrocyte marker. Figure 5e (center and right)
shows examples of dead neurons and oligodendrocytes
near dead astrocytes.
Small molecule and peptide inhibitors of ADCC bystander
killing
We tested three potential inhibitors of ADCC in the NK
cell / CHO coculture model, and one inhibitor in mice
in vivo. To confirm that bystander killing in the in vitro
model is perforin mediated, CHO cell cocultures were
incubated with concanamycin A (CMA) or anti-perforin
antibody (Fig. 6a). CMA inactivates perforin prior to re-
lease by increasing granule pH [29, 65]. Anti-perforin
antibody blocks target cell killing by NK cells by a mech-
anism involving impaired perforin binding to the target
cell surface [30]. We found near-complete prevention of
(See figure on previous page.)
Fig. 2 ADCC bystander killing in cocultures containing AQP4-expressing and null CHO cells. a Cocultures at 1:50 CHO-AQP4:CHO-null cell ratio
were pre-incubated for 30 min with AQP4-IgG (or control IgG) then washed followed by addition of NK cells with a fixable dead cell stain at 30
min prior to fixation. b AQP4 immunofluorescence (green) with dead cell stain (red) at low magnification (left) in cocultures incubated with 5 μg/
ml AQP4-IgG and NK cells at an effector:target cell ratio of 5:1. Three fields at high magnification are shown (right). c Fraction of red-stained, dead
CHO-null cells as a function of distance from dead CHO-AQP4 cells (mean ± S.E.M., 5 slides with > 80 dead cells analyzed, ** P<0.01, *P<0.05
comparing AQP4-IgG + NK vs. control IgG + NK or AQP4-IgG or pure CHO-null cells by two-way ANOVA). d Fraction of dead bystander cells, as in
(c), as a function of incubation time with NK cells (mean ± S.E.M., 5 slides, ** P<0.01 by unpaired t test). Inset shows representative fields at 15 min
and 30 min. White filled arrow indicates dead CHO-AQP4 cell at 30 min. e Control studies including CHO-AQP4 and CHO-null cocultures
incubated with 5 μg/ml control IgG and NK cells at an effector:target cell ratio of 5:1, with AQP4-IgG alone, and pure CHO-null cells incubated
with AQP4-IgG and NK cells. f Cocultures were incubated with NK cells and 1% serum from two seropositive NMO patients, and immunostained
as in panel (b)
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target and bystander cell killing by CMA or anti-
perforin antibody (Fig. 6b), supporting the conclusion
that perforin is the major cytotoxic granule component
in the model system studied here.
If ADCC bystander killing involves physical movement
of an activated NK cell from a target CHO-AQP4 cell to
a nearby bystander cell, then inhibition of NK cell adhe-
sion to target cells might reduce bystander cell killing.
NK-cell mediated ADCC can involve LFA-1/ICAM-1
interaction [7, 61], though CHO cells do not express
ICAM-1 at significant levels [5, 56], nor do astrocytes
under resting conditions [1, 58]. Integrin-mediated
(See figure on previous page.)
Fig. 3 Mechanism of ADCC bystander killing. a Perforin immunofluorescence of CHO-AQP4 and CHO-null cocultures after pre-coating with AQP4-
IgG and incubation NK cells, as in Fig. 2b, with controls including control IgG and NK cells, and AQP4-IgG alone. White filled arrows indicate
perforin on AQP4-expressing CHO cells, white open arrows show perforin on CHO-null cells. b Time-lapse imaging of coculture of CHO-AQP4
cells (labeled green with cell tracker) and CHO-null cells, pre-incubated for 30 min AQP4-IgG, then at indicated times after NK cell addition (for
explanation see text and Additional file 2: Video S2)
a
b
d
c
Fig. 4 ADCC bystander killing in astrocyte-neuron cocultures. a Astrocyte-neuron cocultures following 30 min pre-coating with AQP4-IgG and 2 h
incubation with NK cells at an effector:target cell ratio of 5:1, with fixable dead cell marker added for the final 30 min. GFAP (astrocyte) and MAP2
(neuron) immunofluorescence, with dead cells stained red, shown at high (left) and low (right) magnifications. Yellow filled arrows indicate dead
astrocytes, yellow open arrows show dead neurons. b Fraction of dead neurons at different distances from the center of dead astrocytes
(mean ± S.E.M., 3 slides with > 30 dead cells analyzed, ** P<0.01, *P<0.05 comparing AQP4-IgG + NK vs. control IgG + NK or AQP4-IgG without NK
cells by two-way ANOVA). c Perforin immunofluorescence (red) of cocultures treated as in a. with GFAP (green) and MAP2 (gray)
immunofluorescence. Yellow filled arrows indicate perforin on astrocytes, yellow open arrows show perforin on neurons. d AQP4
immunofluorescence (green) with dead cell stain (red) and DAPI (blue) at high (left) and low (center) magnifications in CHO-AQP4 and CHO-null
cocultures following 5 μg/ml AQP4-IgG and neutrophils at an effector:target cell ratio of 5:1. Yellow filled arrows indicate dead CHO-AQP4 cells,
yellow open arrows show dead CHO-null cells. (Right) Fraction of dead CHO-null cells at different distances from the center of dead CHO-AQP4
cells (mean ± S.E.M., 3 slides with > 50 dead cells analyzed, ** P<0.01, *P<0.05 comparing AQP4-IgG + neutrophils vs. neutrophils or pure CHO-null
cells by two-way ANOVA)
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Fig. 5 ADCC bystander killing in mouse brain. a Mice were administered AQP4-IgG or control IgG (4 μg) and dead cell stain EH-1 (3 μM) with or
without GFP-NK cells (104 cells) by intracerebral injection and sacrificed at 90 min. b Low-magnification confocal microscopy showing dead cells
(red EH-1 fluorescence) and green immunostained NK cells. c High-magnification confocal images of AQP4+/+ or AQP4-/- mice treated as in a,
showing dead cells (red), GFP-NK cells (green), and astrocytes (white). Yellow filled arrows show dead astrocytes, yellow open arrows show dead
bystander cells. d Fraction of dead astrocytes associated with 0, 1 or≥ 2 dead bystander cells (mean ± S.E.M., 5 slides with > 30 dead cells
analyzed). e High-magnification confocal images of mice treated as in a, with indicated stain combinations. Yellow filled arrows show dead
astrocytes, yellow open arrows show dead bystander cells some of which were NeuN-positive (neurons) or Olig2-positive (oligodendrocytes)
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signaling may facilitate ADCC in the absence of ICAM-
1 [3]. As integrin adhesion generally involves the min-
imal integrin binding motif Arg-Gly-Asp (RGD) [28],
RGD-containing peptides can block integrin-associated
cell adhesion [8, 13, 17, 50] and inhibit degranulation of
cytotoxic lymphocytes [18]. CHO cells express multiple
integrins, including αvβ3 and αIIbβ3, which can be
blocked by RGDS peptide [14]. Figure 6c shows reduced
ADCC bystander killing by Arg-Gly-Asp-Ser (RGDS)
peptide preincubation, without significant effect of con-
trol peptide (Arg-Gly-Glu-Ser, RGES). The peptides did
not impair killing of CHO-AQP4 target cells (Fig. 6d, left
panel). Figure 6d (right panel) summarizes the fraction
of dead CHO-null cells at different distances from the
center of dead AQP4-expressing CHO cells, showing the
RGDS preferentially reduces bystander killing within
100 μm of dead CHO-AQP4 cells.
As intracerebral injection of RGDS peptides has dem-
onstrated utility in treating N-methyl-D-aspartate-medi-
ated brain excitotoxicity [43], we studied RGDS action
in the mice in which the peptide (or control RGES) was
administered by intracerebral injection together with
AQP4-IgG and NK cells. At low magnification, staining
with EH-1 was much reduced with RGDS peptide
a
b
e f
d
c
Fig. 6 Inhibition of ADCC bystander killing by small molecule, antibody and peptide inhibitors. a CMA and anti-perforin antibody. Cocultures of
CHO-AQP4 and CHO-null cell were incubated for 30 min with AQP4-IgG then washed and exposed for 1 h to NK cells with or without CMA (10
nM), and with or without added anti-perforin antibody (10 μg/ml), with fixable dead cell stain added 30 min prior to fixation. b Fraction of dead
cells in cocultures from studies as in a (mean ± S.E.M., 4 slides with > 60 dead cells analyzed, ** P<0.01 by unpaired t test). c RGDS peptide.
Cocultures were pre-incubated with AQP4-IgG then washed and incubated with RGDS peptide (or control RGES peptide) (200 μM) for 1 h, then
exposed to NK cells with dead cell stain added 30 min prior to fixation. d (Left) Cultures treated as in c, showing fraction of dead CHO-AQP4 cells
in cocultures with no peptide or RGDS or RGES (mean ± S.E.M., 4 slides with > 30 dead cells analyzed). (Right) Fraction of red-stained, dead CHO-
null cells as a function of distance from dead CHO-AQP4 cells (mean ± S.E.M., 4 slides with > 60 dead cells analyzed, ** P<0.01, *P<0.05 comparing
no-peptide vs. RGDS or RGES by two-way ANOVA). e Mice were injected with RGDS and RGES peptides (on contralateral side), together with
AQP4-IgG (4 μg), NK cells (104 cells) and dead cell stain EH-1 (3 μM). (Left) Low magnification showing EH-1 positive cells. (Right) High
magnification confocal images showing dead cells (red), astrocytes (green) and neurons (blue). Yellow filled arrows show dead astrocytes, yellow
open arrows show dead bystander cells. f Fraction of dead astrocytes associated with 0, 1 or ≥ 2 dead bystander cells in sections of brains from
RGDS and RGES treated mice (mean ± S.E.M., 5 slides with > 30 dead cells analyzed)
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compared with control RGES peptide in the contralat-
eral hemisphere (Fig. 6e, left). Higher magnification
(right panel) shows that the dead cells with RGDS pep-
tide consisted mainly of GFAP-immunopositive astro-
cytes, whereas many GFAP-negative cells were killed
with control peptide, some of which were NeuN-positive
neurons. Quantification of images in Fig. 6f showed a
significant redistribution of the cell killing profile to as-
trocytes vs. bystander cells with RGDS peptide.
Discussion
The results here extend prior evidence on ADCC as a
complement-independent mechanism of astrocyte injury
in AQP4-IgG-seropositive NMOSD [34, 45, 47, 67, 68].
We show ADCC bystander killing as an additional
pathogenesis mechanism linking AQP4-IgG binding to
AQP4 on astrocytes with injury to other cell types in the
central nervous system, such as neurons and oligoden-
drocytes, and consequent neurological deficit. ADCC by-
stander killing was demonstrated in AQP4-transfected
CHO cell / null cell and astrocyte / neuron co-cultures
using NK cells or neutrophils as the effector cells.
Distance-dependent bystander cell killing and perforin
immunofluorescence provided evidence in support of an
ADCC bystander mechanism. The range of bystander
killing in ADCC extended well beyond that seen with
complement bystander injury in the same coculture sys-
tem, with killing seen to 300 μm with ADCC compared
to < 100 μm with CDC, demonstrating ADCC bystander
injury has a greater range of action than complement by-
stander injury. Time-lapse imaging revealed NK cell acti-
vation upon binding to AQP4-IgG on CHO-AQP4 cells
and physical movement to nearby cells, producing se-
quential attack of both the target and bystander cells in
a contact-dependent manner. This movement of acti-
vated NK cell leads to a greater distance range for
ADCC bystander killing than that for complement by-
stander killing. Within the distance range of ADCC by-
stander effect, whether a particular bystander cell is
killed depends on contact with an activated NK cell with
remaining cytotoxic granules and effective delivery of
granule contents. Therefore, only a fraction of bystander
cells are killed in a stochastic manner within the effect-
ive distance range of ADCC bystander killing.
Figure 7 depicts potential mechanisms of ADCC by-
stander killing in NMO. AQP4-IgG binds to AQP4 on
astrocytes, which allows binding and activation of NK
cells through Fcγ receptors. Activated NK cells can in-
duce bystander cell injury by several mechanisms, in-
cluding: (i) targeted lytic protein secretion onto
immediately adjacent bystander cells following activa-
tion; (ii) sequential attack of target cell followed by re-
lease and binding/attack of a nearby bystander cell; and
(iii) release of soluble granule contents following
activation that then diffuse through the extracellular
medium and are deposited on nearby cells. Cytotoxic
lymphocytes such as NK cells and cytotoxic T-
lymphocytes store a variety of cytotoxic proteins within
lytic granules, including perforin and granzyme, which
are released after antigen-stimulated degranulation [59].
Target cell death relies on the diffusion of the secreted
cytolytic proteins through the extracellular matrix to
reach their target [48]. Perforin creates large pores on
the plasma membrane of target cells, similar to mem-
brane attack complex in complement-dependent cyto-
toxicity, which facilitate access of granzyme to the
cytosol and subsequent cell lysis [64].
Off-target deposition of perforin by activated NK cells
has been shown to injure bystander cells in other sys-
tems. Co-stimulation of Fcγ receptors (CD16) and LFA-
1 was demonstrated to mediate cell specificity and re-
duce bystander killing of non-adherent Drosophila S2
cells [9]. In contrast, NK cells activated by CD16 alone,
without LFA-1 co-stimulation, trigger bystander cell lysis
by non-directional secretion of lytic granules [26]. In our
experiments, NK cells were activated by AQP4-IgG
coated cells by CD16 alone, as CHO cells do not en-
dogenously express LFA-1 ligands, suggesting nonspe-
cific release of perforin and local killing of bystander
cells. However, by time-lapse imaging, we found that NK
cells sequentially kill CHO-AQP4 cells followed by bind-
ing to and killing of nearby null cells, and that integrin
blockade with an RGD peptide reduced bystander kill-
ing. This finding supports a modified mechanism of by-
stander killing in which sequential binding to bystander
cells by CD16-activated NK cells causes targeted de-
granulation and cell death, consistent with data showing
that NK cells induce serial killing at a single-cell level
[15]. Other studies reported that killing of a target cell
requires only one-hundredth of the total lytic granule
content of an NK cell [22], which make them capable of
disengaging from one target cell to serially kill additional
target cells. The inhibition of cell killing by CMA and
anti-perforin antibody suggests that both target and by-
stander cell lysis is perforin-dependent; however, it is
possible that additional Fas-dependent cell killing may
occur on longer time scales [2].
It remains to be determined if the ‘serial bystander’
killing described here is a general phenomenon or spe-
cific to AQP4-IgG activated NK cells. The M23 isoform
of AQP4 forms large semi-crystalline macromolecular
aggregates called orthogonal arrays of particles (OAPs)
that are unique to this protein and that can bind several
AQP4-IgG antibodies simultaneously [16, 44]. Though
CDC requires AQP4 aggregation into OAPs for multiva-
lent interaction between AQP4-IgG and complement
protein C1q, ADCC is relatively insensitive to the AQP4
aggregation state [44]. Large OAPs can be removed from
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the membrane of cells [57], which might provide a
mechanism for sustained signaling via CD16 after NK
cell disengagement from an M23-expressing target cell.
Neutrophils, eosinophils and macrophages are abun-
dantly seen in lesions in human seropositive NMOSD
[33, 37, 49, 52], with NK cells and cytotoxic T-
lymphocytes observed less frequently [51]. Each of these
cell types express Fc receptors that can bind to the Fc
moiety of AQP4-IgG. Recent studies have shown that
neutrophils can mediate ADCC by mechanisms includ-
ing degranulation of cytotoxic molecules [1] and releas-
ing of neutrophil extracellular traps [12, 55], as well as
inducing apoptosis [25], autophagy [6] and trogocytosis
[36, 62]. We found here that neutrophils not only cause
ADCC, but also ADCC bystander injury, demonstrating
target non-specificity as a common feature of multiple
ADCC mechanisms in NMO.
Though our results demonstrate complement-
independent ADCC bystander killing in in vitro and
mouse models of NMO, the study here cannot prove
directly that ADCC bystander injury occurs in human
seropositive NMO. In order to identify dead bystander
cells in vivo, our NMO mouse model necessitated syn-
chronizing injection of AQP4-IgG, NK cells and a dead
cell marker and sacrifice at an early time point. Various
leukocytes, including granulocytes and NK cells, can be
short-lived after their entry into the central nervous sys-
tem and activation [9], so that their paucity or absence
does not rule out a role in NMO disease pathogenesis.
Further, the lack of availability of central nervous system
tissue during acute NMO attacks limits the extrapolation
of animal data to human NMO. However, the leukocyte
infiltration in necrotic lesions in post-mortem NMO
samples [33, 37, 49] suggests these cells play a role in
widespread tissue damage.
Conclusions
In conclusion, our results support an ADCC bystander
killing mechanism for injury to non-AQP4-expressing
cells in the central nervous system following AQP4-IgG
Fig. 7 Proposed mechanisms of ADCC bystander killing in AQP4-IgG seropositive NMOSD. Diagram shows AQP4-IgG binding to AQP4 on
astrocytes, with binding and activation of NK cells through Fcγ receptors. Activated NK cells can induce bystander cell damage via three
mechanisms, including: (i) targeted lytic protein secretion onto immediately adjacent bystander cells following activation; (ii) sequential attack of
target cells followed by release and binding/attack of a nearby bystander cell; and (iii) release of soluble granule contents following activation
that then diffuse through the extracellular medium and are deposited on nearby cells
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binding to astrocytes and leukocyte activation through
Fcγ receptor interaction. The close proximity and inter-
mingling of astrocytes and their processes with multiple
cell types, including neurons and oligodendrocytes,
would amplify bystander killing efficiency when com-
pared to in vitro studies done on planar cell monolayers.
Unlike complement bystander injury, ADCC bystander
injury is independent of cell-specific expression of com-
plement regulator proteins proteins such as CD55 and
CD59, and so could produce injury to cell types that are
relatively resistant to complement injury. An ADCC by-
stander injury mechanism would suggest the potential
utility of NMO therapies directed against new targets
such as perforin and leukocyte co-receptors involved in
granule release, as well as adhesion molecules involved
in leukocyte-bystander cell interaction.
Additional files
Additional file 1: Video S1. Complement bystander killing in CHO-
AQP4 and CHO-null cell coculture. Time-lapse imaging showing injured
CHO-AQP4 cells (labeled with green cell tracker) and nearby CHO-null
cells with uptake of dead cell marker EH-1 (red) following addition of
10 μg/ml AQP4-IgG and 5% human complement. Video includes a 30
min baseline recording with AQP4-IgG alone, with human complement
added at 30 min. (AVI 3262 kb)
Additional file 2: Video S2 ADCC bystander killing in CHO-AQP4 and
CHO-null cell cocultures. Time-lapse imaging of coculture of CHO-AQP4
cells (labeled green with cell tracker) and CHO-null cells, pre-incubated
for 30 min with AQP4-IgG, followed by NK cell addition at an
effector:target cell ratio of 5:1. Solutions contained dead cell marker EH-1
(red). (AVI 4219 kb)
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